Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
05/2005
05/26/2005US20050113378 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis
05/26/2005US20050112406 Organometallic complexes and organic electroluminescence device using the same
05/26/2005CA2545350A1 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors
05/26/2005CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
05/25/2005EP1533292A1 Dibenzylamine compound and medicinal use thereof
05/25/2005EP1532128A1 Inhibitors of hcv ns5b polymerase
05/25/2005EP1532111A1 2,5-disubstituted 3-mercaptopentanoic acid
05/25/2005EP1531815A1 Glucokinase activators
05/25/2005EP1531814A1 Sustained-release tablet composition of pramipexole
05/25/2005EP1531812A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis
05/25/2005EP1286673B1 Ligands of integrin receptors
05/25/2005EP1213287B1 Substituted benzylthiazolidine-2,4-dione derivatives
05/25/2005EP1207158B1 Substituted benzylthiazolidine-2,4-dione derivatives
05/25/2005EP1183247B1 Polycyclic thiazole systems and their utilization as anorectics
05/25/2005EP0904274B1 Farnesyl transferase inhibitors
05/25/2005DE10352082A1 Hexylcarboxanilide Hexylcarboxanilides
05/25/2005DE10352067A1 Isopentylcarboxanilide Isopentylcarboxanilide
05/25/2005DE10349502A1 1,3-Dimethylbutylcarboxanilide 1,3-Dimethylbutylcarboxanilide
05/25/2005DE10347383A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors
05/25/2005CN1620442A Five-membered-ring compound
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/25/2005CN1620292A Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
05/25/2005CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors
05/25/2005CN1202823C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack
05/25/2005CN1202821C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (MIDDM) attack
05/24/2005US6897220 Antiproliferative agents
05/24/2005US6896891 Non-systemic control of parasites
05/19/2005WO2005044810A1 Glyt2 modulators
05/19/2005WO2005044804A1 Method for the production of fluoromethyl-substituted heterocycles
05/19/2005WO2005044263A1 Substituted 4-aryloxy and 4-arylsulfanyl-phenyl-2-aminothiazoles as inhibitors of cell proliferation
05/19/2005WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
05/19/2005WO2005028429A3 Haloalkyl containing compounds as cysteine protease inhibitors
05/19/2005WO2004050645A8 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
05/19/2005US20050107449 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X
05/19/2005US20050107448 Calcium receptor antagonists
05/19/2005US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/19/2005US20050107442 Compounds that modulate PPAR activity and methods of preparation
05/19/2005US20050107392 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate
05/19/2005US20050107383 such as 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile; for farm and garden pests including mites, lepidopterans, hemipterans, hymenopterans, orthopterans and isopterans; antiviral agent, fungicide, herbicide
05/19/2005US20050107379 antithrombolytic agents such as (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide, used for therapy of cardiovascular disorders
05/19/2005US20050107354 Preventive or therapeutic agent for kidney disease
05/19/2005US20050107347 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
05/19/2005US20050107309 Lowering elevated post-prandial blood glucose levels by increasing incretin half-life comprising administering inhibitor of Dipeptidyl Peptidase (DP IV) or enzymes having DP-IV-like activity; insulinotropic effects are enhanced
05/19/2005DE10347386A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors
05/19/2005DE10346939A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases
05/18/2005EP1531153A1 Epothilone derivatives
05/18/2005EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
05/18/2005EP1207156B1 Substituted benzylthiazolidine-2,4-dione derivatives
05/18/2005EP1176139B1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors
05/18/2005CN1617865A Phenylalkynes
05/18/2005CN1617854A Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
05/18/2005CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/18/2005CN1617850A Dibenzylamine compound and medicinal use thereof
05/18/2005CN1617720A Use of pramipexole to treat amyotrophic lateral sclerosis
05/18/2005CN1616591A Luminous material and organic electroluminescent luminous device
05/18/2005CN1616453A Antivirally active heterocyclic azahexane derivatives
05/18/2005CN1616439A Improved method for preparing thiazolidine-2, 4-diketo derivative
05/18/2005CN1202096C 2-aminothiazoline derivatives and their use as no-synthase inhibitors
05/18/2005CN1201820C Compositions containing benzimidazolones and progestogens
05/17/2005US6894173 Intermediates useful for synthesis of heteroaryl-substituted urea compounds, and processes of making same
05/17/2005US6894170 Process for the preparation of substituted thiazolines and their intermediates
05/17/2005US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus
05/17/2005US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/17/2005US6893774 For use in electrolytes, primary batteries, secondary batteries, capacitors, supercapacitors or galvanic cells
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/12/2005WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005WO2005042505A1 Thiozolidinones, production and use thereof as medicaments
05/12/2005WO2005042494A1 Isopentyl carboxanilides for combating undesired micro-organisms
05/12/2005WO2005042493A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
05/12/2005WO2005042492A1 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
05/12/2005WO2005042474A1 Diamine derivative, process for producing the same, and plant disease control agent containing the same as active ingredient
05/12/2005WO2005042444A2 Platinum complex and luminescent element
05/12/2005WO2005021519A3 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
05/12/2005WO2005021490A3 N-SULFONYL-α-AMINO-ACID DERIVATIVES
05/12/2005WO2005012273A3 Process for the preparation of substituted thiazoles
05/12/2005WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
05/12/2005US20050101783 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide
05/12/2005US20050101782 Process for the preparation of substituted thiazolines and their intermediates
05/12/2005US20050101642 Niacinamide derivatives as inhibitor of poly(ADP-ribose)polymerase; ranitidine, cimetidine, famotidine, nizatidine as gastric acid secretion control; immunomodulation and suppression of hypersensitivity and inflammatory reaction; IgE mediated allergic reaction; no side effects; virtually non-toxic
05/12/2005US20050101590 Cannabinoid receptor agonists
05/12/2005CA2544267A1 Thiazolidinones, production and use thereof as medicaments
05/12/2005CA2543054A1 Isopentylcarboxanilides for combating undesired micro-organisms
05/12/2005CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005CA2540460A1 Heterocyclic compounds and methods of making and using thereof
05/11/2005EP1529816A1 Azo dye
05/11/2005EP1529530A1 Compounds affecting glucokinase
05/11/2005EP1529038A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
05/11/2005EP1529037A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
05/11/2005EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
05/11/2005EP1311494B1 Continuous process for the preparation of pesticidal chlorothiazoles
05/11/2005EP1157015B1 Use of polycyclic 2-amino-thiazole systems for the manufacture of medicaments for the treatment of lipometabolic disorders, obesitas and typ ii diabetes
05/11/2005EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
05/11/2005CN1615311A 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
05/11/2005CN1615305A Coumarin derivatives, process for their production and use thereof
05/11/2005CN1615299A Xanthine oxidase inhibitors
05/10/2005US6890956 Cyclohexyl sulphones as gamma-secretase inhibitors
05/06/2005WO2005040355A2 Tao kinase modulators and methods of use
05/06/2005WO2005040161A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications
05/06/2005WO2005040138A1 Substituted benzylaminoalkylene heterocycles
05/06/2005WO2005040129A2 Ccr3 receptor antagonists
1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 337